Heart device watchdog: 5,000-Patient registry launches

NCT ID NCT04241328

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry is an observational study that will follow 5,000 people who receive a Medtronic heart surgery device. Its goal is to confirm the devices are safe and work well in everyday use, and to spot any new risks. No new treatment is being tested—just real-world monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AKH Wien

    RECRUITING

    Vienna, 1090, Austria

    Contact

  • CHU d'Angers

    COMPLETED

    Angers, France

  • Catharina Ziekenhuis

    COMPLETED

    Eindhoven, 5623 EJ, Netherlands

  • Clinique Claude Bernard

    TERMINATED

    Metz, 57070, France

  • Deutsches Herzzentrum München

    RECRUITING

    Munich, 80636, Germany

    Contact

  • Haukeland Universitetssjukehus

    SUSPENDED

    Bergen, Norway

  • Herz- und Diabeteszentrum NRW

    RECRUITING

    Bad Oeynhausen, Germany

    Contact

  • Hospital Clinic Barcelona

    COMPLETED

    Barcelona, 08036, Spain

  • Maastricht University Medical Center (MUMC+)

    ACTIVE_NOT_RECRUITING

    Maastricht, 6229 HX, Netherlands

  • Onassis Hospital

    ACTIVE_NOT_RECRUITING

    Athens, Greece

  • St. Antonius Ziekenhuis

    RECRUITING

    Nieuwegein, Netherlands

    Contact

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

    Contact

  • Uniklinik RWTH Aachen

    RECRUITING

    Aachen, Germany

    Contact

  • Ziekenhuis Oost-Limburg

    RECRUITING

    Genk, 3600, Belgium

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.